In this edition, Natalie Yeadons sits down with Jon Sockell, Co-founder and COO of Limbix. Limbix Spark is the first prescription digital therapeutic designed to support adolescents with depression. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials, tribulations, successes, and vision for the future. Get inspired to ask your next big question or navigate into some new uncharted waters for your company. This is a time of unprecedented change. It is an opportunity to leverage these days of variance and to create differentiation using "functional speed". Jon will get us all motivated to leverage the groundswell of momentum that is swirling around us in this new post-COVID-19 #newnormal world in which we live!

Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.com

Impetus Digital Website: https://www.impetusdigital.com/

Impetus Digital Twitter: https://twitter.com/Impetusadboards

Impetus YouTube: https://www.youtube.com/Impetushealthcare

Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Jon Sockell: https://www.linkedin.com/in/jsockell/

Limbix: https://www.limbix.com/

Twitter Mentions